A cewar hukumar bincike kan cutar daji ta hukumar lafiya ta duniya, a shekarar 2020, kasar Sin ta sami sabbin cututtukan daji kusan miliyan 4.57, inda cutar kansar huhu ta kai kusan 820,000.Bisa ka'idar da cibiyar kula da cutar kansa ta kasar Sin ta fitar ta ce, "Shawarwari don tantance cutar daji ta huhu da gano cutar da wuri da kuma magance cutar kansa a kasar Sin," yawan kamuwa da cutar kansar huhu da mace-mace a kasar Sin ya kai kashi 37% da kashi 39.8 na kididdigar duniya, bi da bi.Wadannan alkalumman sun zarce adadin yawan jama'ar kasar Sin, wanda ya kai kusan kashi 18% na yawan al'ummar duniya.
Ma'anar kumaSub-irina ciwon huhu
Ma'anar:Ciwon daji na huhu na farko, wanda aka fi sani da kansar huhu, shine mafi yawan ƙwayar cuta ta farko wacce ta samo asali daga trachea, mucosa na buroshi, ƙananan buroshi, ko gland a cikin huhu.
Dangane da halayen histopathological, Cutar sankarar huhu za a iya rarraba zuwa cikin ciwon huhu mara ƙananan ƙwayoyin cuta (80% -85%) da ƙananan ciwon huhu (15% -20%), wanda ke da matsayi mafi girma na malignancy.Ciwon daji na huhu mara karami ya hada da adenocarcinoma, carcinoma cell cell carcinoma, da kuma manyan carcinoma cell.
Dangane da wurin da abin ya faru, cutar sankarar huhu za a iya ƙara zama a matsayin ciwon huhu na tsakiya da kuma ciwon huhu na gefe.
Ganewar Cutar Ciwon Ciwon Huhu
Ciwon Kankara ta Tsakiya:Yana nufin ciwon huhu wanda ya samo asali daga bronchi sama da matakin yanki, da farko ya ƙunshisquamous cell carcinoma da ƙananan ciwon huhu. Ana iya samun ganewar asali na pathological yawanci ta hanyar bronchoscopy na fiber.Yin aikin tiyata na ciwon daji na huhu na tsakiya yana da ƙalubale, kuma galibi ana iyakance shi zuwa gama gamawar huhu da abin ya shafa.Marasa lafiya na iya samun wahalar jure wa hanya, kuma saboda ci gaba da ci gaba, mamayewa na gida, ƙwayar ƙwayar ƙwayar cuta ta mediastinal metastasis, da sauran dalilai, sakamakon aikin tiyata bazai zama mai kyau ba, tare da haɗarin haɓakar ƙashi.
Ciwon daji na huhu:Yana nufin ciwon daji na huhu da ke faruwa a ƙasan bronchi na yanki,da farko ciki har da adenocarcinoma. Ana samun ganewar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan ƙwayoyin cuta waɗanda CT ke jagoranta.A cikin aikin asibiti, ciwon huhu na huhu sau da yawa yana asymptomatic a farkon matakan kuma ana gano shi akai-akai yayin gwajin jiki.Idan an gano shi da wuri, tiyata shine zaɓin jiyya na farko, sannan kuma maganin chemotherapy na adjuvant ko maganin da aka yi niyya.
Ga masu ciwon huhu na huhu waɗanda ba su cancanci yin tiyata ba, suna da tabbataccen ganewar asali na cututtukan cututtukan da ke buƙatar magani na gaba, ko buƙatar bi-bi-bi-a-da-mamaki ko magani bayan tiyata,daidaitaccen magani da dacewa yana da mahimmanci musamman.Muna son gabatar muku da kuDr. An Tongtong, ƙwararren ƙwararren ƙwararrun ƙwararrun ƙwanƙwasa tare da fiye da shekaru 20 na gwaninta a fannin ilimin likitanci a Sashen Kula da Oncology na Thoracic, Asibitin Ciwon daji na Jami'ar Beijing.
Shahararren Kwararre: Dr. An Tongtong
Babban Likita, Likitan Magunguna.Tare da gogewar bincike a MD Anderson Cancer Center a Amurka, da kuma mamban kwamitin matasa na kwamitin kwararrun masu fama da cutar kansa na kasar Sin.
Wuraren Ƙwarewa:Chemotherapy da kwayoyin da aka yi niyya don ciwon huhu, thymoma, mesothelioma, da bincike da hanyoyin warkewa kamar bronchoscopy da aikin tiyata na thoracic na taimakon bidiyo a cikin maganin ciki.
Dokta An ya gudanar da bincike mai zurfi game da daidaitawa da kuma cikakkiyar jiyya mai mahimmanci na ciwon daji na huhu,musamman a cikin mahallin cikakken jiyya na daidaikun mutane don ciwon huhu mara ƙanƙanta.Dr. An ƙware ne a cikin sabbin ƙa'idodin bincike na duniya da kuma hanyoyin warkewa don ciwace-ciwacen daji.A lokacin shawarwari, Dr. An cikakken fahimtar tarihin likitancin mai haƙuri kuma yana sa ido sosai kan canje-canjen cutar a kan lokaci.Ya kuma yi bincike a hankali game da bincike na baya da tsare-tsaren jiyya don tabbatar da daidaitawa akan lokaci na mafi ingantaccen tsarin jiyya na mutum ɗaya don majiyyaci.Ga sababbin marasa lafiya da aka gano, rahotanni masu alaƙa da gwaje-gwaje sau da yawa ba su cika ba.Bayan samun cikakkiyar fahimtar tarihin likita, Dokta An zai bayyana a fili dabarun jiyya don yanayin halin yanzu ga mai haƙuri da danginsu.Har ila yau, zai ba da jagora kan yadda ake buƙatar ƙarin gwaje-gwaje don taimakawa wajen tabbatar da ganewar asali, tabbatar da cewa 'yan uwa sun fahimci cikakkiyar fahimta kafin su bar su da majiyyaci su bar ɗakin shawarwari tare da kwanciyar hankali.
Al'amuran Kwanan nan
Mista Wang, mai shekaru 59 da haihuwa mai fama da ciwon huhu na adenocarcinoma mai fama da ciwon huhu da yawa, ya nemi magani a birnin Beijing a lokacin barkewar cutar a karshen shekarar 2022. Saboda takunkumin tafiye-tafiye a lokacin, dole ne ya karbi zagayen farko na maganin chemotherapy a kusa. asibiti bayan an tabbatar da ganewar asali.Duk da haka, Mr. Wang ya sami babban guba na chemotherapy da kuma rashin lafiyar jiki saboda haɗuwa da hypoalbuminemia.
Da yake kusa da zagaye na biyu na chemotherapy, danginsa, sun damu da yanayinsa, sun tambayi gwanintar Dr. An kuma a ƙarshe sun yi nasarar yin alƙawari a sabis na VIP Outpatient na Asibitinmu.Bayan cikakken nazarin tarihin likita, Dr. An ba da shawarwarin magani.Dangane da ƙananan matakan albumin na Mr. Wang da halayen chemotherapy, Dokta An daidaita tsarin chemotherapy ta hanyar maye gurbin paclitaxel tare da pemetrexed yayin haɗa bisphosphonates don hana lalata kashi.
Bayan samun sakamakon gwajin kwayoyin halitta, Dr. An kara dacewa da Mista Wang tare da maganin da ya dace, Osimertinib.Bayan watanni biyu, yayin ziyarar da suka kai, dangin Mr. Wang sun ba da rahoton cewa yanayinsa ya inganta, tare da raguwar alamomi da kuma ikon yin ayyuka kamar tafiya, shayar da tsire-tsire, da share ƙasa a gida.Dangane da sakamakon binciken da aka yi, Dr. An ya shawarci Mista Wang da ya ci gaba da tsarin kula da lafiyar da ake da shi a halin yanzu da kuma duba lafiyarsa akai-akai.
Lokacin aikawa: Agusta-31-2023